Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Hepatic Fat in Adolescents with PCOS
NCT02500147Phase 4Terminated
- Sponsor
- Columbia University
- Start
- Sep 2011
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin in non-alcoholic fatty liver disease (NAFLD), polycystic ovary syndrome (PCOS), sponsored by Columbia University. Started Sep 2011; status: terminated.
02
Drugs
metformin
03
Conditions
non-alcoholic fatty liver disease (NAFLD)polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT02500147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02500147.